Crown Partners successfully arranged $30 million of senior financing from a leading US commercial bank for HGS BioScience, LLC (“HGS”), a portfolio company of Paine Schwartz Partners.  The firm served as exclusive financial advisor to HGS in connection with this transaction.
 
Crown was chosen for its specialized expertise in the asset-based financing market, which allowed HGS to access efficient low-cost growth capital by leveraging its asset base. Crown simultaneously arranged a revolving credit facility and equipment & IP term loan to maximize liquidity generated by the transaction.

“The Crown team proved incredibly valuable in advising us on our strategy for approaching the asset-based financing market to best serve HGS’s business plan, balancing flexibility, cost and long term partnership.  I appreciate the Crown’s team rigor and attention to detail regarding each step of our capital raising process.” -- John Novak, Head of Investment Development & Capital Markets, Paine Schwartz Partners

HGS is the world’s largest manufacturer of extracted powder and granule humates and is a major manufacturer of liquid humic and fulvic acid products.  Its products are used by agribusiness customers to improve soil health and enhance the yield potential of crops.  Based in Jacksonville, Florida, HGS has a North American footprint of six manufacturing plants and serves customers in 20+ countries.  HGS has an aggressive growth plan over the next 5 years, positioning the Company as the global leader in humic substances.

“Crown congratulates HGS on closing this senior financing as it executes on its growth plan.  We appreciate the opportunity to work with the PSP and HGS deal teams in accessing the bank asset-based financing market, to produce a robust solution that supports its growth on a capital efficient basis.” -- Mark Seigel and Evan Nadler